Literature DB >> 19740334

Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling.

Carsten Linnemann1, Frank A Schildberg, Anna Schurich, Linda Diehl, Silke I Hegenbarth, Elmar Endl, Svenja Lacher, Christa E Müller, Jürgen Frey, Luca Simeoni, Burkhart Schraven, Dirk Stabenow, Percy A Knolle.   

Abstract

Adenosine is a well-described anti-inflammatory modulator of immune responses within peripheral tissues. Extracellular adenosine accumulates in inflamed and damaged tissues and inhibits the effector functions of various immune cell populations, including CD8 T cells. However, it remains unclear whether extracellular adenosine also regulates the initial activation of naïve CD8 T cells by professional and semi-professional antigen-presenting cells, which determines their differentiation into effector or tolerant CD8 T cells, respectively. We show that adenosine inhibited the initial activation of murine naïve CD8 T cells after alphaCD3/CD28-mediated stimulation. Adenosine caused inhibition of activation, cytokine production, metabolic activity, proliferation and ultimately effector differentiation of naïve CD8 T cells. Remarkably, adenosine interfered efficiently with CD8 T-cell priming by professional antigen-presenting cells (dendritic cells) and semi-professional antigen-presenting cells (liver sinusoidal endothelial cells). Further analysis of the underlying mechanisms demonstrated that adenosine prevented rapid tyrosine phosphorylation of the key kinase ZAP-70 as well as Akt and ERK1/2 in naïve alphaCD3/CD28-stimulated CD8 cells. Consequently, alphaCD3/CD28-induced calcium-influx into CD8 cells was reduced by exposure to adenosine. Our results support the notion that extracellular adenosine controls membrane-proximal T-cell receptor signalling and thereby also differentiation of naïve CD8 T cells. These data raise the possibility that extracellular adenosine has a physiological role in the regulation of CD8 T-cell priming and differentiation in peripheral organs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740334      PMCID: PMC2753927          DOI: 10.1111/j.1365-2567.2009.03075.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  50 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.

Authors:  A Ohta; M Sitkovsky
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

3.  The CD28 signaling pathway regulates glucose metabolism.

Authors:  Kenneth A Frauwirth; James L Riley; Marian H Harris; Richard V Parry; Jeffrey C Rathmell; David R Plas; Rebecca L Elstrom; Carl H June; Craig B Thompson
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

Review 4.  Steady-state and inflammatory dendritic-cell development.

Authors:  Ken Shortman; Shalin H Naik
Journal:  Nat Rev Immunol       Date:  2006-12-15       Impact factor: 53.106

Review 5.  Complex regulation of nucleoside transporter expression in epithelial and immune system cells.

Authors:  M Pastor-Anglada; F J Casado; R Valdés; J Mata; J García-Manteiga; M Molina
Journal:  Mol Membr Biol       Date:  2001 Jan-Mar       Impact factor: 2.857

6.  Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.

Authors:  David W Hoskin; Jared J Butler; Dennis Drapeau; S M Mansour Haeryfar; Jonathan Blay
Journal:  Int J Cancer       Date:  2002-05-20       Impact factor: 7.396

7.  Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.

Authors:  Kristin Synnestvedt; Glenn T Furuta; Katrina M Comerford; Nancy Louis; Jorn Karhausen; Holger K Eltzschig; Karl R Hansen; Linda F Thompson; Sean P Colgan
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

8.  Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation.

Authors:  Marc Pouliot; Marie-Elaine Fiset; Mireille Massé; Paul H Naccache; Pierre Borgeat
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

9.  cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression.

Authors:  Thomas Grader-Beck; Andre A F L van Puijenbroek; Lee M Nadler; Vassiliki A Boussiotis
Journal:  Blood       Date:  2002-09-19       Impact factor: 22.113

Review 10.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

View more
  45 in total

Review 1.  Regulation of lymphocyte function by adenosine.

Authors:  Joel Linden; Caglar Cekic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-05       Impact factor: 8.311

2.  Tumor-infiltrating CD39+γδTregs are novel immunosuppressive T cells in human colorectal cancer.

Authors:  Guoming Hu; Pin Wu; Pu Cheng; Zhigang Zhang; Zhen Wang; Xiuyan Yu; Xuan Shao; Dang Wu; Jun Ye; Tao Zhang; Xiaochen Wang; Fuming Qiu; Jun Yan; Jian Huang
Journal:  Oncoimmunology       Date:  2017-01-06       Impact factor: 8.110

Review 3.  Purinergic regulation of the immune system.

Authors:  Caglar Cekic; Joel Linden
Journal:  Nat Rev Immunol       Date:  2016-03       Impact factor: 53.106

Review 4.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

Review 5.  Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints.

Authors:  Kristian M Hargadon
Journal:  Clin Transl Med       Date:  2020-01

Review 6.  Immunological alterations mediated by adenosine during host-microbial interactions.

Authors:  Ioannis Drygiannakis; Peter B Ernst; David Lowe; Ian J Glomski
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

7.  Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity.

Authors:  Divya Sekar; Christina Hahn; Bernhard Brüne; Edward Roberts; Andreas Weigert
Journal:  Eur J Immunol       Date:  2012-06       Impact factor: 5.532

Review 8.  Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.

Authors:  Michail Sitkovsky; Akio Ohta
Journal:  J Mol Med (Berl)       Date:  2013-01-20       Impact factor: 4.599

Review 9.  The adenosine pathway in immuno-oncology.

Authors:  Bertrand Allard; David Allard; Laurence Buisseret; John Stagg
Journal:  Nat Rev Clin Oncol       Date:  2020-06-08       Impact factor: 66.675

Review 10.  Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers.

Authors:  M F Tolba; H Elghazaly; E Bousoik; M M A Elmazar; S M Tolaney
Journal:  Clin Transl Oncol       Date:  2021-04-19       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.